
Thermo Fisher Scientific TMO
€ 495.56
0.41%
Quartalsbericht 2025-Q3
hinzugefügt 31.10.2025
Thermo Fisher Scientific Betriebsaufwand 2011-2025 | TMO
Betriebsaufwand Jährlich Thermo Fisher Scientific
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 7.15 B | 7.02 B | 6.38 B | 5.73 B | 5.3 B | 5.59 B | 3.84 B | 3.73 B | 3.47 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.15 B | 3.47 B | 5.36 B |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
29.2 M | $ 19.0 | -1.91 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.7 | -2.24 % | $ 223 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 0.23 | -3.87 % | $ 6.75 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 39.2 | -0.51 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 230.43 | 0.05 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.56 | 5.18 % | $ 300 M | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.51 | -0.95 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.85 | 0.28 % | $ 18.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
DexCom
DXCM
|
1.69 B | $ 67.71 | 0.21 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 26.63 | -0.34 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
484 M | $ 19.04 | -2.26 % | $ 1.02 B | ||
|
Celcuity
CELC
|
113 M | $ 101.24 | -0.99 % | $ 3.99 B | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 3.19 | -0.47 % | $ 102 K | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 226.71 | -0.09 % | $ 41.1 B | ||
|
Guardant Health
GH
|
226 M | $ 101.95 | -1.01 % | $ 12.5 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 7.23 | 1.4 % | $ 1.57 B | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
709 M | $ 6.35 | -2.01 % | $ 575 M | ||
|
National Research Corporation
NRC
|
38.5 M | $ 18.92 | 1.39 % | $ 464 M | ||
|
ENDRA Life Sciences
NDRA
|
10.8 M | $ 4.81 | -5.39 % | $ 2.58 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.26 | 0.55 % | $ 20 B | ||
|
Personalis
PSNL
|
44.5 M | $ 8.05 | -1.11 % | $ 477 M | ||
|
Quidel Corporation
QDEL
|
285 M | $ 29.14 | -0.56 % | $ 1.23 B | ||
|
Illumina
ILMN
|
3.69 B | $ 133.97 | -0.73 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 203.01 | -0.32 % | $ 10.4 B | ||
|
RadNet
RDNT
|
1.73 B | $ 73.05 | -0.14 % | $ 5.34 B | ||
|
Soleno Therapeutics
SLNO
|
188 M | $ 47.74 | 0.19 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 175.29 | -0.37 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
106 M | $ 6.73 | -1.32 % | $ 873 M | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 252.89 | -0.39 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 182.85 | 0.01 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
1.25 B | $ 683.4 | -0.74 % | $ 56.4 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 67.01 | 0.45 % | $ 4.64 B | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 413.2 | -0.49 % | $ 30 B |